Selected article for: "drug efficacy and major effect"

Author: Gonçalves, Antonio; Bertrand, Julie; Ke, Ruian; Comets, Emmanuelle; de Lamballerie, Xavier; Malvy, Denis; Pizzorno, Andrés; Terrier, Olivier; Rosa Calatrava, Manuel; Mentré, France; Smith, Patrick; Perelson, Alan S; Guedj, Jérémie
Title: Timing of antiviral treatment initiation is critical to reduce SARS‐CoV‐2 viral load
  • Cord-id: osolval7
  • Document date: 2020_6_18
  • ID: osolval7
    Snippet: We modeled the viral dynamics of 13 untreated patients infected with SARS‐CoV‐2 to infer viral growth parameters and predict the effects of antiviral treatments. In order to reduce peak viral load by more than 2 logs, drug efficacy needs to be greater than 90% if treatment is administered after symptom onset; an efficacy of 60% could be sufficient if treatment is initiated before symptom onset. Given their pharmacokinetic/pharmacodynamic properties, current investigated drugs may be in a ran
    Document: We modeled the viral dynamics of 13 untreated patients infected with SARS‐CoV‐2 to infer viral growth parameters and predict the effects of antiviral treatments. In order to reduce peak viral load by more than 2 logs, drug efficacy needs to be greater than 90% if treatment is administered after symptom onset; an efficacy of 60% could be sufficient if treatment is initiated before symptom onset. Given their pharmacokinetic/pharmacodynamic properties, current investigated drugs may be in a range of 6‐87% efficacy. They may help control virus if administered very early, but may not have a major effect in severe patients.

    Search related documents:
    Co phrase search for related documents
    • active metabolite and loading dose: 1, 2, 3, 4
    • active metabolite and log10 viral load: 1
    • active metabolite and lopinavir ritonavir: 1
    • acute infection and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute infection and additional compartment: 1
    • acute infection and load dynamic: 1
    • acute infection and loading dose: 1, 2
    • acute infection and log10 viral load: 1
    • acute infection and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute infection and low respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute infection and low respiratory tract: 1, 2, 3, 4, 5, 6, 7
    • acute infection and low respiratory tract viral load: 1
    • adaptive immune response and lopinavir ritonavir: 1
    • loading dose and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7
    • lopinavir ritonavir and low respiratory: 1, 2
    • lopinavir ritonavir and low respiratory tract: 1